Lv1
28 积分 2024-06-11 加入
Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study
1个月前
已完结
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Efficacy and safety of pharmacological intervention for smoking cessation in smokers with diseases: A systematic review and network meta‐analysis
4个月前
已完结
Systematic Review and Network Meta‐Analysis of the Comparative Effectiveness of Adherence Enhancement Strategies in Chronic Kidney Disease
4个月前
已完结
Efficacy and safety of various corticosteroids in the treatment of children with allergic rhinitis: A systematic review and network meta‐analysis
4个月前
已完结
Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial
9个月前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
11个月前
已完结
Switching ahead of progression: Insights from the SERENA-6 trial on targeting emerging ESR1 mutations in advanced HR+/HER2- breast cancer
11个月前
已关闭
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
1年前
已完结
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
1年前
已完结
皖公网安备34019202002308
